GLP-1 Therapy & Skin Changes: Evidence-Based Guide Skin maintenance during GLP-1 therapy recommendations are increasingly sought as medications such as semaglutide (Ozempic, Wegovy) and liraglutide (Saxenda, Victoza) become more widely prescribed for type 2 diabetes and weight management in the UK
Diabetic neuropathy differs between type 1 and type 2 diabetes: insights from magnetic resonance neurography
FDA Removes GHK-Cu from Category 2: What Peptide Users Need to Know On April 15, 2026, the FDA announced a significant regulatory update: injectable GHK-Cu (copper tripeptide-1) will be removed from the Category 2 bulk substances list by July 2026
The question is whether the added glucagon receptor effects, including the heart rate increase, will enhance, diminish, or have no effect on that protection
What works for someone optimizing peak performance differs dramatically from whats needed for someone experiencing trouble losing weight, battling daily fatigue, or dealing with brain fog that makes it feel like their brains not working properly